New York’s Food Safety and Chemical Disclosure Act (S1239F) has passed both houses of the state legislature and was delivered to the Governor on November 13, 2026. If it is signed, companies could no longer sell or use a self-affirmed GRAS substance in food sold in New York unless a detailed safety report on that substance has been filed with the state and published in a public online database. For ingredient suppliers and food manufacturers relying on internal GRAS determinations that have never been submitted to the FDA, this would be a material shift in how that safety data is treated.
The bill does more than add a reporting requirement. It would also ban three substances in food sold in New York: FD&C Red No. 3, potassium bromate and propylparaben. Taken together, these measures make S1239F a significant state-level food safety law, and a New York GRAS bill that ingredient suppliers and food manufacturers selling into the New York market should follow closely.
What S1239F Would Require
Under the bill, it would be unlawful to sell a GRAS substance for use in food, use it to manufacture or process food, make any new use of it, or sell food containing it, unless a report on that substance has been submitted to the Commissioner of Agriculture and Markets and made available in the state’s public database. The report must set out the scientific basis for the GRAS determination in detail. A report that has been published covers later uses of the same GRAS substance under the same conditions of intended use, regardless of who submitted it, and the Commissioner may refuse to list a report that does not contain the required information.
This is a direct departure from current practice. Under the federal framework, companies may conclude on their own that a substance is GRAS without notifying the FDA, a pathway critics often call the “GRAS loophole.” S1239F would require state-level disclosure of those determinations for food sold in New York. The database would be searchable and downloadable by the public. The Commissioner must redact information the submitter designates as a trade secret, but the data establishing general recognition of safety cannot be redacted, and the bill states that this data must be based on publicly available information rather than trade secrets.
Which Substances Are Exempt
The reporting requirement does not apply to every GRAS substance. The bill exempts:
- GRAS substances for which the FDA has received a GRAS notification and issued a “no questions” letter for the intended conditions of use;
- substances recognized in federal regulations as prior-sanctioned or GRAS for use in food or food packaging;
- food contact substances with an effective premarket notification;
- substances covered by a regulation approving their intended use in food;
- food ingredients widely consumed in the United States before January 1, 1958 without known detrimental effects, subject only to conventional processing as practised before that date, and with no known safety hazard;
- substances for which the FDA has acknowledged a new dietary ingredient notification without objection; and
- substances the Commissioner determines to be safe through rulemaking.
The bill also exempts small businesses, defined as businesses that are independently owned and operated and employ 100 or fewer people, and it applies only to food for human consumption. For companies with mixed GRAS ingredients portfolios, the practical question is which substances rest only on an internal GRAS determination. A GRAS notice that did not end in a “no questions” letter, for example one the FDA stopped evaluating at the notifier’s request, does not qualify for the first exemption.
The Additive Prohibitions
Separate from the disclosure requirements, S1239F would make it unlawful to manufacture, sell, distribute or hold for sale in New York any food containing FD&C Red No. 3, potassium bromate or propylparaben, starting one year after the act takes effect. Retailers, food service establishments and food relief organizations could continue selling products they acquired before the act took effect until the printed expiration, “best by” or “sell by” date, but no later than three years after the effective date. California’s Food Safety Act, signed in 2023, bans the same three substances along with brominated vegetable oil. Companies selling into New York should confirm whether any current formulations contain these three substances.
How FDA Recognition Is Treated in Enforcement
The bill gives the Commissioner authority to take legal action, including seeking an injunction, to enforce the new GRAS reporting section and the additive prohibitions. Published summaries of the bill, including the summary on the New York State Senate website, state that FDA recognition of a substance as safe may not be used as a defence. The amended bill text (S1239F) reads differently: it keeps the existing provision that, in actions to enforce the food additive sections of the law, FDA recognition of a food additive or color additive as safe “may be alleged as a proper defense.”
Because the bill text and the published summaries do not line up on this point, companies should not assume either reading is settled. Holding an FDA “no questions” letter does exempt a substance from the reporting requirement, but it has no bearing on the three-substance ban, and how FDA recognition would be treated in an enforcement action should be reviewed with legal counsel once the final law and any implementing rules are available.
What This Means for Your Business
For food manufacturers and ingredient suppliers, the practical implications of S1239F fall into two categories: disclosure readiness and formulation review.
On the disclosure side, companies relying on self-affirmed GRAS determinations should assess whether their documentation would meet the bill’s reporting requirements and hold up under public scrutiny. The report must include a certification that it is complete, representative and balanced, with unfavourable as well as favourable information, and the safety data cannot be withheld as a trade secret. A GRAS determination prepared mainly for internal files may need significant work to meet that standard.
On the formulation side, the additive prohibitions create a separate and concrete task. If any product sold in New York contains Red No. 3, potassium bromate or propylparaben, reformulation planning should start well before the ban applies. Lead times for formulation changes, re-testing and regulatory review can be substantial.
Quality Smart Solutions advises clients to use the period before the act takes effect to review GRAS documentation and ingredient inventories. Regardless of the Governor’s decision on S1239F, state-level food safety legislation is moving toward greater transparency around ingredient safety data. Companies that have documented their self-affirmed GRAS determinations thoroughly will be better positioned for whichever requirements take effect.
Frequently Asked Questions
Would S1239F apply to my products if I sell into New York but manufacture outside the state?
Yes, if your products are sold in New York and contain a GRAS substance that is not exempt and has no published report. The prohibitions cover selling or offering for sale any food containing an unreported GRAS substance in the state, not only manufacturing there. Retailers are protected from liability for selling such products if they hold a written contract in which the supplier confirms the products comply, so New York retailers are likely to ask suppliers for that confirmation. Businesses with 100 or fewer employees that are independently owned and operated are exempt from the reporting requirement.
If I have already submitted a GRAS notification to the FDA and received a "no questions" letter, am I exempt from the S1239F disclosure requirement?
Yes, for the conditions of use covered by that letter. The bill exempts any GRAS substance for which the FDA has received a GRAS notice and responded that it has no questions about the GRAS conclusion under the substance's intended conditions of use. A new use outside those conditions would need to be assessed separately. The exemption does not affect the separate ban on FD&C Red No. 3, potassium bromate and propylparaben, which applies regardless of GRAS status.
What level of documentation would a safety report need to contain to satisfy the S1239F requirement?
The bill sets out detailed required contents, closely following the structure of an FDA GRAS notice. The report must include signed statements and certifications; the substance's identity, method of manufacture, specifications and technical effect; dietary exposure estimates from all sources in the diet; any self-limiting levels of use; evidence of common use in food before 1958 where that is the basis for GRAS status; a narrative explaining the GRAS conclusion, including any data that may appear inconsistent with it; a list of the generally available data relied on; any previous GRAS notices to the FDA and the FDA's responses; and all relevant safety information currently available. Companies whose internal GRAS files were prepared on the assumption they would remain confidential should compare them against these requirements now.
Key Takeaways
- New York’s Food Safety and Chemical Disclosure Act (S1239F) passed both houses of the legislature and was delivered to the Governor on November 13, 2026.
- If signed, selling or using a non-exempt GRAS substance in food sold in New York would require a published safety report in a public state database, and the data establishing safety could not be redacted as a trade secret.
- Exemptions include substances with an FDA “no questions” letter, substances listed in federal regulations, acknowledged new dietary ingredients and small businesses with 100 or fewer employees.
- The bill would ban FD&C Red No. 3, potassium bromate and propylparaben in food sold in New York one year after the act takes effect, with a limited sell-through period for retailers.
- The bill text and the published summaries differ on whether FDA recognition can be used as a defence in enforcement actions, so companies should review this point with counsel once the law is final.
Preparing Now Before the Law Takes Effect
S1239F now awaits the Governor’s decision. If signed, the act would take effect one year later, and the GRAS reporting requirement would apply from that date. Its passage reflects a broader state-level move toward mandatory transparency around ingredient safety decisions. For companies that have relied on self-affirmed GRAS determinations without notifying the FDA, reviewing GRAS files against the bill’s reporting requirements, checking formulations for the three banned substances and confirming which ingredients qualify for an exemption are practical steps that make sense regardless of the outcome.
To assess whether your existing GRAS determinations are documented well enough for a public disclosure environment, contact Quality Smart Solutions to speak with a regulatory specialist about your ingredient portfolio






